IL85897A0 - Method of diagnosing obesity caused by a genetic abnormality - Google Patents
Method of diagnosing obesity caused by a genetic abnormalityInfo
- Publication number
- IL85897A0 IL85897A0 IL85897A IL8589788A IL85897A0 IL 85897 A0 IL85897 A0 IL 85897A0 IL 85897 A IL85897 A IL 85897A IL 8589788 A IL8589788 A IL 8589788A IL 85897 A0 IL85897 A0 IL 85897A0
- Authority
- IL
- Israel
- Prior art keywords
- genetic abnormality
- adipsin
- obesity caused
- abnormality
- diagnosing obesity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3420387A | 1987-04-02 | 1987-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL85897A0 true IL85897A0 (en) | 1988-09-30 |
Family
ID=21874944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL85897A IL85897A0 (en) | 1987-04-02 | 1988-03-29 | Method of diagnosing obesity caused by a genetic abnormality |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0382720B1 (de) |
| JP (1) | JPH02503229A (de) |
| AT (1) | ATE80465T1 (de) |
| AU (1) | AU606946B2 (de) |
| DE (1) | DE3874543T2 (de) |
| DK (1) | DK675388A (de) |
| ES (1) | ES2046325T3 (de) |
| FI (1) | FI894592A0 (de) |
| GR (1) | GR3005716T3 (de) |
| IL (1) | IL85897A0 (de) |
| NO (1) | NO885360L (de) |
| WO (1) | WO1988007681A1 (de) |
| ZA (1) | ZA882288B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2084062A1 (en) * | 1990-06-01 | 1991-12-02 | Ginette Serrero | Mammalian adipogenic factors |
| US20060263774A1 (en) * | 2002-11-01 | 2006-11-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US10328131B2 (en) | 2014-03-13 | 2019-06-25 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for regulating pancreatic beta cell function using adipsin |
| DE102014107380A1 (de) | 2014-05-26 | 2015-11-26 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür |
-
1988
- 1988-03-29 WO PCT/US1988/000999 patent/WO1988007681A1/en not_active Ceased
- 1988-03-29 AU AU15913/88A patent/AU606946B2/en not_active Ceased
- 1988-03-29 AT AT88903655T patent/ATE80465T1/de not_active IP Right Cessation
- 1988-03-29 DE DE8888903655T patent/DE3874543T2/de not_active Expired - Fee Related
- 1988-03-29 JP JP63503418A patent/JPH02503229A/ja active Pending
- 1988-03-29 IL IL85897A patent/IL85897A0/xx unknown
- 1988-03-29 EP EP88903655A patent/EP0382720B1/de not_active Expired - Lifetime
- 1988-03-29 FI FI894592A patent/FI894592A0/fi not_active Application Discontinuation
- 1988-03-30 ES ES198888810211T patent/ES2046325T3/es not_active Expired - Lifetime
- 1988-03-30 EP EP88810211A patent/EP0287509B1/de not_active Expired - Lifetime
- 1988-03-30 ZA ZA882288A patent/ZA882288B/xx unknown
- 1988-12-01 NO NO88885360A patent/NO885360L/no unknown
- 1988-12-02 DK DK675388A patent/DK675388A/da not_active Application Discontinuation
-
1992
- 1992-09-17 GR GR920401980T patent/GR3005716T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA882288B (en) | 1988-12-28 |
| DK675388D0 (da) | 1988-12-02 |
| EP0287509B1 (de) | 1992-09-16 |
| DE3874543T2 (de) | 1993-02-04 |
| AU1591388A (en) | 1988-11-02 |
| EP0382720A1 (de) | 1990-08-22 |
| EP0287509A1 (de) | 1988-10-19 |
| EP0382720B1 (de) | 1992-09-09 |
| FI894592A7 (fi) | 1989-09-28 |
| ATE80465T1 (de) | 1992-09-15 |
| EP0382720A4 (en) | 1991-01-02 |
| AU606946B2 (en) | 1991-02-21 |
| FI894592L (fi) | 1989-09-28 |
| NO885360L (no) | 1989-02-01 |
| ES2046325T3 (es) | 1994-02-01 |
| FI894592A0 (fi) | 1989-09-28 |
| WO1988007681A1 (en) | 1988-10-06 |
| DK675388A (da) | 1988-12-02 |
| JPH02503229A (ja) | 1990-10-04 |
| GR3005716T3 (de) | 1993-06-07 |
| NO885360D0 (no) | 1988-12-01 |
| DE3874543D1 (de) | 1992-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE269978T1 (de) | Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit | |
| EP1019072A4 (de) | Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen | |
| GB8710925D0 (en) | Type iii collagen degradation assay | |
| EP0625991A4 (de) | Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute. | |
| HARRINGTON et al. | The association between lichen sclerosus et atrophicus and HLA‐B40 | |
| IL85897A0 (en) | Method of diagnosing obesity caused by a genetic abnormality | |
| Simpson et al. | Effect of zimelidine, a new antidepressant, on appetite and body weight | |
| ZA92389B (en) | Method for detection of anti-rna-antibodies | |
| Björkholm et al. | Immunological defects in healthy twin siblings to patients with Hodgkin's disease | |
| Nicholson et al. | The creatine kinase reference interval: An assessment of intra-and inter-individual Variation | |
| Nakamura et al. | A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy | |
| Zschiedrich et al. | Urinary kallikrein in normotensive subjects and in patients with essential hypertension | |
| Merluzzi et al. | Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of Lyt-1+ 2− helper cells | |
| SKOUBY | Hydroxocobalamin for Initial and Long‐term Therapy for Vitamin B12 Deficiency | |
| Scharf et al. | Transverse myelitis with systemic lupus erythematosus | |
| DE3572033D1 (en) | Method for diagnosis of a.i.d.s. | |
| Leisti et al. | Phenotypic variation in alpha-L-iduronidase deficiency | |
| SU943578A1 (ru) | Способ определени суточной дозы гепарина | |
| Goldstein | Carbamazepine treatment for stuttering. | |
| DE69028023D1 (de) | Verfahren zur Bestimmung des Cholesterins, zum Nachweis von Gefässkrankheiten und zur Anhebung des Anteils an HDL-Cholesterin | |
| SU787995A1 (ru) | Способ дифференцировани т и в лимфоцитов человека | |
| Gately et al. | Effect of anti-lymphotoxin on cell-mediated cytotoxicity: Evidence for two pathways of cytolysis | |
| Digel et al. | Induction of interferon gamma in leucocyte cultures of the peripheral blood of mice | |
| Lijnen et al. | Effect of aspirin on renal function and the prostaglandin-kallikrein systems early after myocardial infarction | |
| UA6102A1 (uk) | Спосіб визначення індивідуальної чутливості хворих до кемантану при хронічному обструктивному бронхіті |